Dr. Zilberberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
421 N Main St
Leeds, MA 01053Phone+1 413-268-3414Fax+1 413-268-3416
Education & Training
Tufts Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998- Tufts Medical CenterResidency, Internal Medicine, 1992 - 1995
Boston University School of MedicineClass of 1992
Publications & Presentations
PubMed
- Unfavorable Outcomes and Their Risk Factors in Hospitalized Patients withBacteremia in the US: A Multicenter Retrospective Cohort Study, 2020-2022.Marya D Zilberberg, Brian H Nathanson, Rolf Wagenaar, Jan Posthumus, Andrew F Shorr
Antibiotics. 2025-03-20 - Complex Infections: New Treatment Options in the Antibiotic Pipeline.Noayna Arshad, Wael Azzam, Marya D Zilberberg, Andrew F Shorr
Microorganisms. 2025-02-07 - Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021.Marya D Zilberberg, Brian H Nathanson, Mark A Redell, Kate Sulham, Andrew F Shorr
Antibiotics. 2025-01-03
Press Mentions
Testing and Treatment in Patients Hospitalized with Suspected Influenza PneumoniaOctober 5th, 2019- The Answer for Inhaled Antibiotics in Pneumonia Is Still Blowing in the WindJune 26th, 2017
Achaogen Announces Data on Epidemiological Trends of Carbapenem-Resistant Enterobacteriaceae at SHEA Spring 2017 ConferenceMarch 29th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
